Aszalós Zsuzsa
Semmelweis Egyetem, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika.
Orv Hetil. 2006 Apr 30;147(17):773-83.
Insomnia and depression are widespread diseases causing deterioration of life's quality and increasing morbidity and mortality of cardiovascular diseases. Both of them and certain antidepressants adversely affect physiological structure of sleep, while others restore it. The latter drugs must be preferred in therapy of depression accompanying insomnia, and some of them may be effective in treatment of insomnias without depression. Most antidepressants cause REM-reduction, generally with increased serotonin-function. Selective H1-antagonists readily induce sleep, and also the inhibition of cholinergic neurons in the general arousal networks promotes sleep. Sleep continuity is improved by the rise of synaptic level of serotonin. Among tricyclic antidepressants trimipramine and amitriptyline are the best to improve sleep. However, the former has low antidepressant effect and the latter has many adverse side effects. Selective serotonin reuptake inhibitors, except paroxetine, improve sleep only at the time and to the extent of restoring depression. Paroxetine has beneficial effect on sleep at the beginning of the treatment. Mirtazapine is the first-line sleep promoter among atypical antidepressants, however, its effect on increasing appetite markedly limits its application. Trazodone causes hangover, and mianserin may induce restless legs. Insomnias without depression demand lower dose of antidepressants than depression.
失眠和抑郁症是常见疾病,会导致生活质量下降,增加心血管疾病的发病率和死亡率。它们以及某些抗抑郁药都会对睡眠的生理结构产生不利影响,而其他一些药物则能恢复睡眠。在治疗伴有失眠的抑郁症时,应优先选用后者,其中一些药物对治疗无抑郁症的失眠也可能有效。大多数抗抑郁药会减少快速眼动睡眠,通常伴随着血清素功能增强。选择性H1拮抗剂容易诱导睡眠,而且抑制一般觉醒网络中的胆碱能神经元也有助于睡眠。血清素突触水平的升高可改善睡眠连续性。在三环类抗抑郁药中,曲米帕明和阿米替林对改善睡眠效果最佳。然而,前者的抗抑郁效果较低,后者有许多不良副作用。除帕罗西汀外,选择性5-羟色胺再摄取抑制剂仅在恢复抑郁状态时及程度上改善睡眠。帕罗西汀在治疗开始时对睡眠有有益作用。米氮平是非典型抗抑郁药中一线的促眠药物,然而,其增加食欲的作用明显限制了其应用。曲唑酮会导致宿醉,米安色林可能会诱发不宁腿。无抑郁症的失眠患者所需的抗抑郁药剂量低于抑郁症患者。